title: Bone involvement in myelofibrosis: effectiveness of bisphosphonates.
authors.forename: Noémie
authors.initials: N
authors.lastname: Assous
authors.forename: Violaine
authors.initials: V
authors.lastname: Foltz
authors.forename: Bruno
authors.initials: B
authors.lastname: Fautrel
authors.forename: Sylvie
authors.initials: S
authors.lastname: Rozenberg
authors.forename: Fabien
authors.initials: F
authors.lastname: Etchepare
authors.forename: Pierre
authors.initials: P
authors.lastname: Bourgeois
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000209:etiology*; D000077268:Pamidronate; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy*; D011877:Radionuclide Imaging
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077268:Pamidronate